EGFR activating mutations

Related by string. * eGFR . EGFr : EGFR mutations . HuMax EGFr . HuMax EGFr TM . EGFR expressing mCRC . EGFR signaling pathway / Activating . ACTIVATED . activAT . activated : Catalytic Activated Vacuum Distillation . activating mutations . activated charcoal . secretly activating webcams / Mutations . Mutation : gene mutation . gene mutations . G#D mutation . genetic mutations identical * *

Related by context. Frequent words. (Click for all words.) 68 BRAF mutation 63 KRAS mutations 62 EGFR mutations 60 EGFR inhibitors 59 FLT3 59 K RAS 59 EpCAM 58 myeloma cells 57 T#I mutation 57 androgen independent 57 HER2/neu 56 gefitinib 55 imetelstat 55 HER2 positive metastatic breast 55 hematological cancers 54 neoplastic 54 castration resistant prostate cancer 54 EGFR 54 hepatocellular carcinoma HCC 54 gastric cancers 54 NSCLC 54 breast carcinoma 54 EGFRvIII 54 HGS ETR1 54 CR# vcMMAE 54 neuroendocrine tumors 53 EGFr 53 talabostat 53 CD# antigen 53 ErbB 53 squamous 53 hematopoietic cell 53 ovarian breast 53 metastatic tumors 53 MAb 53 transfected 53 PARP inhibitor 52 lymphoid 52 epithelial cell 52 Her2 52 chronic HBV infection 52 BCR ABL 52 survivin 52 tumor antigens 52 HER-2/neu 52 adenocarcinomas 52 PCa 52 non squamous 52 cells hESCs 52 genotypic 52 estrogen receptor ER 52 lung adenocarcinoma 52 susceptibility genes 52 AP# [003] 52 IMC A# 52 Aurora kinase 52 peripheral blood mononuclear 52 colorectal tumors 52 tumors 51 ErbB2 51 CA4P 51 CYC# 51 tyrosine kinase inhibitor 51 hepatocellular carcinoma 51 malignant pleural mesothelioma 51 superficial bladder cancer 51 refractory multiple myeloma 51 myeloid 51 hematologic malignancies 51 PXD# 51 pertuzumab 51 GRN#L 51 cytomegalovirus CMV 51 thymalfasin 51 HCV infected 51 metastatic hormone refractory 51 MUC1 51 subpopulation 51 tyrosine kinase inhibitors 51 metastatic renal cell carcinoma 51 Imprime PGG 51 recurrent ovarian cancer 51 progesterone receptor 50 etoposide 50 JAK2 50 HER2 negative 50 endometrial cancers 50 medullary thyroid cancer 50 heavily pretreated 50 IGF 1R 50 erlotinib 50 romidepsin 50 antitumor activity 50 CD# [002] 50 advanced NSCLC 50 liver metastases 50 factor receptor EGFR 50 luteinizing hormone releasing 50 seliciclib 50 solid tumors 50 unresectable

Back to home page